Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Significance of flavonoids targeting PI3K/Akt/HIF-1α signaling pathway in therapy-resistant cancer cells - A potential contribution to the predictive, preventive, and personalized medicine.
Mazurakova A, Koklesova L, Csizmár SH, Samec M, Brockmueller A, Šudomová M, Biringer K, Kudela E, Pec M, Samuel SM, Kassayova M, Hassan STS, Smejkal K, Shakibaei M, Büsselberg D, Saso L, Kubatka P, Golubnitschaja O. Mazurakova A, et al. Among authors: busselberg d. J Adv Res. 2024 Jan;55:103-118. doi: 10.1016/j.jare.2023.02.015. Epub 2023 Mar 4. J Adv Res. 2024. PMID: 36871616 Free PMC article. Review.
Role of flavonoids in controlling obesity: molecular targets and mechanisms.
Mahboob A, Samuel SM, Mohamed A, Wani MY, Ghorbel S, Miled N, Büsselberg D, Chaari A. Mahboob A, et al. Among authors: busselberg d. Front Nutr. 2023 May 12;10:1177897. doi: 10.3389/fnut.2023.1177897. eCollection 2023. Front Nutr. 2023. PMID: 37252233 Free PMC article. Review.
Ginsenoside Rg5 as an anticancer drug: a comprehensive review on mechanisms, structure-activity relationship, and prospects for clinical advancement.
Elsaman T, Muddathir AM, Mohieldin EAM, Batubara I, Rahminiwati M, Yamauchi K, Mohamed MA, Asoka SF, Büsselberg D, Habtemariam S, Sharifi-Rad J. Elsaman T, et al. Among authors: busselberg d. Pharmacol Rep. 2024 Apr;76(2):287-306. doi: 10.1007/s43440-024-00586-5. Epub 2024 Mar 25. Pharmacol Rep. 2024. PMID: 38526651 Review.
New insights into the anticancer therapeutic potential of icaritin and its synthetic derivatives.
Reyes-Hernández OD, Figueroa-González G, Quintas-Granados LI, Hernández-Parra H, Peña-Corona SI, Cortés H, Kipchakbayeva A, Mukazhanova Z, Habtemariam S, Leyva-Gómez G, Büsselberg D, Sharifi-Rad J. Reyes-Hernández OD, et al. Among authors: busselberg d. Drug Dev Res. 2024 Apr;85(2):e22175. doi: 10.1002/ddr.22175. Drug Dev Res. 2024. PMID: 38567708 Review.
195 results